Podcasts Other S&C Critical Insights Industry and Regulatory Trends in Pharmaceutical M&A

Industry and Regulatory Trends in Pharmaceutical M&A

Published: March 24, 2021, 7:06 p.m.

b'In this episode of\\xa0S&C\\u2019s\\xa0Critical Insights\\xa0podcast,\\xa0Frank Aquila, Global Head of M&A, and\\xa0Matt Hurd, co-head of our Healthcare & Life Sciences group, examine industry and regulatory trends that will reshape pharmaceutical M&A in the coming years. Frank and Matt explore how innovation continues to drive new deal-making opportunities in the pharmaceutical industry, most recently in the development of non-traditional vaccine technologies. They also discuss the current deal landscape in pharmaceutical M&A and what we can expect from the market in the rest of 2021.'